News About: Pharm. Industry
Hanmi Pharm’s combination drug ‘Gugu Tams’ enters Samsung Medical Center
‘Gugu Tams,’ a Hanmi Pharm’s benign prostatic hyperplasia and erectile dysfunction treatment, entered Samsung Medical Center.
According to the industry concerned, Hanmi Pharm’s Gugu Tams, Novartis’ Fytarex, Hanlim Ph...
Yuhan Corporation President Jung-Hee Lee is now certain for Chair of the KPBMA
It has become certain about the next Chair of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA), which had brought various rumors.
This is because Yuhan Corporation President Jung-Hee Lee has m...
SK Biopharmaceuticals found joint venture with Glycyx
SK Biopharmaceuticals(CEO Jung-Woo Cho) announced the company founded a joint venture to develop Relenopride as a rare nervous disease treatment with Glycyx Therapeutics Ltd. On the 7th. SK Biopharmaceuticals and Glyc...
Dong Wha Pharm’s plan to recruit officers to target OTC field
Dong Wha Pharm has shown a movement towards the OTC field which the company has remained strong so far. Particularly, it was interesting because the management is related to this OTC-related phenomenon.
A part relate...
14 professional managers at listed pharmas, like Yuhan Corporation CEO Jung-Hee Lee, meet end in term of office this year
14 professional managers in the pharmaceutical industry, like CEO Jung-Hee Lee at Yuhan Corporation and CEO Jong-Wook Lee at Daewoong Pharmaceutical, will meet the end in their term of office and most of the terms wil...
‘Pharmaceutical companies need to improve the internal reporting system’
Pharmaceutical companies have inspected themselves in ethical management and the result showed their average score was ‘A.’
‘KPBMA Brief,’ the 14th policy report published by the Korea Pharmaceutical and Bio-Pharma M...
Hanall Biopharma’s global expansion chosen as one of ’10 Most Outstanding Scientific Technology News’
Hanall Biopharma’ large biotechnology export was selected as one of the ’10 Most Outstanding Scientific Technology News of The Year’ by the Korean Federation of Science and Technology Societies(KOFST).
Last December,...
Yuhan Corporation supplies HIV APIs worth of KRW 48.2 billion to Gilead
Yuhan Corporation officially announced conclusion of the supply agreement active pharmaceutical ingredients for the treatment of HIV(HIV API) with ‘Gilead Sciences Ireland UC’ on the 3rd.
Its upfront payment was abou...
Samyang Biopharmaceuticals win patent trial of ‘Palseron’ against global pharmas
Samyang Biopharmaceuticals(CEO Tae-Woong Um) announced on the 3rd the company has won the 1st trial of patent infringement related to ‘Palseron Inj(generic name: palonosetron hydrochloride)’ against Helsinn Healthcare...
Chong Kun Dang makes antidiabetic ‘Duvimet XR Tab’ smaller
Chong Kun Dang(CEO Young-Joo Kim) announced on the 3rd that the company has launched a new product with enhanced convenience by downsizing ‘Duvimet XR Tab,’ a combination drug for the treatment of diabetes.
Duvimet X...
